EU Archives - Bionest

13

Dec 2021

Bionest

UK Policy Changes Allow Earlier Access to Innovative Medicines for Rare Diseases

Access to new treatments for rare diseases in the UK has often been a challenge. Will a new decision-making framework & funding improve the situation?

30

Sep 2019

Bionest

The Missing Piece in the Brexit Prep Jigsaw

After three years since the United Kingdom’s vote to leave the European Union and a number of extensions, the country is fast approaching the latest deadline of October 31, 2019. The new Prime Minister, Boris Johnson, and the leaders of the EU have been at loggerheads, and the possibility of a deal or no deal...

1

Jul 2019

Bionest

Building a Better Market for Biologics: The US vs. Europe

The advent of generics has dramatically impacted the cost of small molecule drugs following the expiry of the patent protection for the originator therapeutics, with the cost of a small molecule generic often as little as 10% of that of the originator drug. This price difference results from several factors, including lower R&D costs, fewer...